3 internationally renowned R&D centers

Ipsen has set-up its R&D centers at the heart of three internationally reputed scientific hubs: Paris-Saclay in France, Oxford in United Kingdom and Cambridge in United States of America. Each site is located close to leading academic research centers, cutting edge medical centers and biotechnological companies. The interactions with these different players in the health industry develop our chances of having access to innovative technologies in order to speed up the discovery and commissioning of drugs and services that improve the lives of patients.

Opened on April 1 2015, the Ipsen Bioscience R&D center in Cambridge is dedicated to conducting research on peptides, mainly in endocrinology and oncology. It is located in an exceptional environment of universities and academic institutions, within one of the largest life sciences hubs. Ipsen’s researchers interact with several American universities and institutions (Harvard, Massachusetts Institute of Technology, etc.), prestigious hospitals and major players in pharmaceuticals, but also a good number of pioneering start-ups including some of Ipsen’s partners. Ipsen is positioning itself at the heart of biological revolution currently underway and to partner with pioneers that drive it.

The expertise available in Cambridge focuses on our knowledge of hormone-dependent physiopathological mechanisms involving neuropeptides and growth factors. It also has a clinical research and development team, tasked with coordinating and conducting clinical research in North America. A dedicated regulatory group focuses on the Ipsen’s regulatory activities with the FDA in the United States.

> €200 M

Expenditure in R&D in 2016

3

World R&D centers

~300

Employees assigned to R&D

Last update 31/08/2016